-
Recent Posts
Archives
Categories
Meta
Category Archives: Update
(Veloci)Raptor’s Rapture
Look. It’s done. Indeed. Believe it or not, this is the second post of the year…and within 10 days of the first. Twice 2012’s output already. More shocking than ODAC’s resounding rejection of $AVEO’s tivozanib on today! —————————————————————————————————————————- I wanted … Continue reading
Posted in I don't get it, Orphan, Pricing, Update
Tagged $ALXN, $RPTP, biotech, DR cyteamine, ERT, pricing, Procysbi, Soliris, strategy
Leave a comment
Crazy way to start 2013
Love or hate it, here’s to the first post of 2013. Given that the site fee was just renewed, I thought that I should post something and get some sort of return… …or so I thought. The plan was to … Continue reading
No, the Broncos did not have gout, but they sure looked slow and in pain against the Pats
(Ack. Wrote this on Friday, and completely forget to post) Here we go – I can’t compete with all the goodies the came out from the JPM Healthcare Conference, but here’s Part II of my six-month update from June. No, … Continue reading
Kicking off the New Year – in June
That was one fast December. It seems like just yesterday that I reviewed my November notes, and boom, here we are, at the end of the first week of January. I expect to be back posting regularly…uh, maybe after the … Continue reading
Posted in Update
Tagged $RPTP, $UGNE, biotech, calcitonin, Cystinosis, oral, PTH, re-repurpose
Leave a comment
Thoughts, six months later
Whoa, what happened out in UC-Davis? Pepper spraying students protesting peacefully? Not right. OK, back to some fun. A half-year. Six-months. 184 days. More grey hairs. This has been a fun experiment. Once a week (or so), I jot down … Continue reading
No, not inhibited ($INHX)
This why biotech is fun. Beginning yesterday and continuing through the weekend, many investors’ eyes will be focused on The Liver Meeting, being held in San Francisco, with the latest advances in liver disease being shared and discussed. The first … Continue reading
Posted in Research, Update
Tagged $IDIX, $INHX, $VRUS, biotech, DAA, HCV, Idenix, Inhibitex, NS5b, Pharmasset, polymerase inhibitor
Leave a comment